Development of High-Titer Antidrug Antibodies in a Phase 1b/2a Infant Clesrovimab Trial Are Associated With RSV Exposure Beyond Day 150

Authors

Institutions

Publication Details

Journal
The Journal of Infectious Diseases
Published
2024-11-26
DOI
https://doi.org/10.1093/infdis/jiae582
Citations
10
Primary Topic
Viral Infections and Immunology Research
Type
article
Field-Weighted Citation Impact
4.02
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of High-Titer Antidrug Antibodies in a Phase 1b/2a Infant Clesrovimab Trial Are Associated With RSV Exposure Beyond Day 150

Carmen Sofia Arriola, Antonios O. Aliprantis, Jia Yao Phuah, Radha Railkar et al.
10 citations
The Journal of Infectious Diseases
Viral Infections and Immunology Research
4.02
article

Development of High-Titer Antidrug Antibodies in a Phase 1b/2a Infant Clesrovimab Trial Are Associated With RSV Exposure Beyond Day 150

Carmen Sofia Arriola, Antonios O. Aliprantis, Jia Yao Phuah, Radha Railkar, Lori M Tobias, Nithya Thambi, Ryan P. Staupe, Yu Cao, Kalpit A. Vora, Troy W. McKelvey, Brian M. Maas
article en
10 citations

Abstract

No abstract available for this paper.
The Journal of Infectious DiseasesVol. 231(3)
Merck & Co., Inc., Rahway, NJ, USA (United States) (US), Bioanalytica (Switzerland) (CH), Decision Sciences (United States) (US)
Good health and well-being
Openalex Percentile: Top 5%
Viral Infections and Immunology Research
4.02
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.